These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3398709)

  • 1. Tolerance to oxotremorine's effects on schedule-controlled behavior in physostigmine-tolerant rats.
    Genovese RF; Elsmore TF; King LR
    Life Sci; 1988; 43(7):571-6. PubMed ID: 3398709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental influences on the development of tolerance to the effects of physostigmine on schedule-controlled behavior.
    Genovese RF; Elsmore TF; Witkin JM
    Psychopharmacology (Berl); 1988; 96(4):462-7. PubMed ID: 3149767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of azaprophen, scopolamine and trihexyphenidyl on schedule-controlled behavior, before and after chronic physostigmine.
    Genovese RF
    Eur J Pharmacol; 1990 Feb; 176(3):271-9. PubMed ID: 2328755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance to behavioral effects of physostigmine under interval schedules of positive or negative reinforcement.
    Galbicka G; Elsmore TF; Witkin JM
    Psychopharmacology (Berl); 1989; 97(4):448-55. PubMed ID: 2498941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in the effects of atropine on the behavior of pigeons following chronic administration.
    Schaal DW; Branch MN
    Pharmacol Biochem Behav; 1987 Nov; 28(3):375-80. PubMed ID: 3685073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of selective central muscarinic blockade on schedule-controlled behavior and on the rate-decreasing effects of physostigmine.
    Hymowitz N; Brezenoff HE
    Pharmacol Biochem Behav; 1984 Jul; 21(1):109-15. PubMed ID: 6463084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centrally active antimuscarinic analogs of oxotremorine selectively block physostigmine-induced hypertension, but not peripheral muscarinic vasodepression.
    Vargas HM; Ringdahl B
    J Pharmacol Exp Ther; 1990 Apr; 253(1):165-70. PubMed ID: 2329503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physostigmine-insensitive behavioral excitatory effects of atropine in squirrel monkeys.
    Witkin JM; Markowitz RA; Barrett JE
    Pharmacol Biochem Behav; 1989 Jan; 32(1):309-15. PubMed ID: 2734342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance to the behavioural effects of physostigmine in rats: lack of importance of behavioural compensation.
    Overstreet DH; Dubas G
    Commun Psychopharmacol; 1978; 2(2):93-8. PubMed ID: 668303
    [No Abstract]   [Full Text] [Related]  

  • 10. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
    Shannon HE; Bemis KG; Hendrix JC; Ward JS
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1071-7. PubMed ID: 2262893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural tolerance to arecoline in rats: cross-tolerance to oxotremorine and prevention by pretreatment with atropine.
    Overstreet DH; Jamal OS
    Psychopharmacology (Berl); 1986; 89(1):118-20. PubMed ID: 3090586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of exercise on behavioral sensitivity to carbamate cholinesterase inhibitors.
    McMaster SB; Finger AV
    Pharmacol Biochem Behav; 1989 Aug; 33(4):811-3. PubMed ID: 2616600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of physostigmine, atropine and scopolamine on behavior maintained by a multiple schedule of food presentation in the mouse.
    Wenger GR
    J Pharmacol Exp Ther; 1979 Apr; 209(1):137-43. PubMed ID: 430373
    [No Abstract]   [Full Text] [Related]  

  • 14. Discriminative stimulus properties of physostigmine in rats.
    Tang AH; Franklin SR
    Eur J Pharmacol; 1988 Aug; 153(1):97-104. PubMed ID: 3215280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of 6-hydroxydopamine on the antinociceptive action of oxotremorine.
    Slater P
    Psychopharmacology (Berl); 1981; 74(4):365-8. PubMed ID: 6794084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional reactivity of central cholinergic systems following desipramine treatments and sleep deprivation.
    Murugaiah KD; Ukponmwan OE
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Oct; 368(4):294-300. PubMed ID: 13680087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of scopolamine and physostigmine on fixed-interval behaviour in the rat.
    McKim WA
    Psychopharmacologia; 1974; 39(3):237-44. PubMed ID: 4427990
    [No Abstract]   [Full Text] [Related]  

  • 18. Tolerance to the effects of buprenorphine on schedule-controlled behavior and analgesia in rats.
    Berthold CW; Moerschbaecher JM
    Pharmacol Biochem Behav; 1988 Feb; 29(2):393-6. PubMed ID: 3362932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance to the disruptive effects of arecoline on schedule-controlled behavior.
    Meltzer LT; Rosecrans JA
    Psychopharmacology (Berl); 1982; 77(1):85-93. PubMed ID: 6812123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of repeated administration of cocaine on schedule-controlled behavior of rats.
    Woolverton WL; Kandel D; Schuster CR
    Pharmacol Biochem Behav; 1978 Sep; 9(3):327-37. PubMed ID: 714982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.